TY - JOUR AU - Burns, M. PY - 1999 DA - 1999// TI - Management of narrow therapeutic index drugs JO - J Thromb Thrombolysis VL - 7 UR - https://doi.org/10.1023/A:1008829403320 DO - 10.1023/A:1008829403320 ID - Burns1999 ER - TY - JOUR AU - Gong, I. Y. AU - Schwarz, U. I. AU - Crown, N. AU - Dresser, G. K. PY - 2011 DA - 2011// TI - Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0027808 DO - 10.1371/journal.pone.0027808 ID - Gong2011 ER - TY - JOUR AU - Johnson, J. A. AU - Gong, L. AU - Whirl-Carrillo, M. AU - Gage, B. F. PY - 2011 DA - 2011// TI - Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing JO - Clin Pharmacol Ther VL - 90 UR - https://doi.org/10.1038/clpt.2011.185 DO - 10.1038/clpt.2011.185 ID - Johnson2011 ER - TY - JOUR AU - Wadelius, M. AU - Pirmohamed, M. PY - 2007 DA - 2007// TI - Pharmacogenetics of warfarin: current status and future challenges JO - Pharmacogenomics J VL - 7 UR - https://doi.org/10.1038/sj.tpj.6500417 DO - 10.1038/sj.tpj.6500417 ID - Wadelius2007 ER - TY - JOUR AU - Bourgeois, S. AU - Jorgensen, A. AU - Zhang, E. J. AU - Hanson, A. PY - 2016 DA - 2016// TI - A multi-factorial analysis of response to warfarin in a UK prospective cohort JO - Genome Med VL - 8 UR - https://doi.org/10.1186/s13073-015-0255-y DO - 10.1186/s13073-015-0255-y ID - Bourgeois2016 ER - TY - JOUR AU - Jorgensen, A. L. AU - FitzGerald, R. J. AU - Oyee, J. AU - Pirmohamed, M. PY - 2012 DA - 2012// TI - Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0044064 DO - 10.1371/journal.pone.0044064 ID - Jorgensen2012 ER - TY - JOUR AU - Yang, J. AU - Chen, Y. AU - Li, X. AU - Wei, X. PY - 2013 DA - 2013// TI - Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis JO - Int J Cardiol VL - 168 UR - https://doi.org/10.1016/j.ijcard.2013.07.151 DO - 10.1016/j.ijcard.2013.07.151 ID - Yang2013 ER - TY - JOUR AU - Francis, B. AU - Lane, S. AU - Pirmohamed, M. AU - Jorgensen, A. PY - 2014 DA - 2014// TI - A review of a priori regression models for warfarin maintenance dose prediction JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0114896 DO - 10.1371/journal.pone.0114896 ID - Francis2014 ER - TY - JOUR PY - 2009 DA - 2009// TI - Estimation of the Warfarin dose with clinical and Pharmacogenetic data JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0809329 DO - 10.1056/NEJMoa0809329 ID - ref9 ER - TY - JOUR AU - Pirmohamed, M. AU - Burnside, G. AU - Eriksson, N. AU - Jorgensen, A. L. PY - 2013 DA - 2013// TI - A randomized trial of genotype-guided dosing of warfarin JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1311386 DO - 10.1056/NEJMoa1311386 ID - Pirmohamed2013 ER - TY - JOUR AU - Pinnock, H. AU - Barwick, M. AU - Carpenter, C. R. AU - Eldridge, S. PY - 2017 DA - 2017// TI - Standards for Reporting Implementation Studies (StaRI) statement JO - BMJ VL - 356 UR - https://doi.org/10.1136/bmj.i6795 DO - 10.1136/bmj.i6795 ID - Pinnock2017 ER - TY - STD TI - www.lgcgroup.com. Accessed 14 Mar 2019. UR - http://www.lgcgroup.com ID - ref12 ER - TY - BOOK PY - 2010 DA - 2010// TI - R: A language and environment for statistical computing PB - R Foundation for Statistical Computing CY - Vienna ID - ref13 ER - TY - JOUR AU - Rosendaal, F. R. AU - Cannegieter, S. C. AU - Meer, F. J. AU - Briet, E. PY - 1993 DA - 1993// TI - A method to determine the optimal intensity of oral anticoagulant therapy JO - Thromb Haemost VL - 69 UR - https://doi.org/10.1055/s-0038-1651587 DO - 10.1055/s-0038-1651587 ID - Rosendaal1993 ER - TY - JOUR AU - Lee, M. T. M. AU - Klein, T. E. PY - 2013 DA - 2013// TI - Pharmacogenetics of Warfarin: challenges and opportunities JO - J Hum Genet VL - 58 UR - https://doi.org/10.1038/jhg.2013.40 DO - 10.1038/jhg.2013.40 ID - Lee2013 ER - TY - JOUR AU - Rothwell, P. M. PY - 2005 DA - 2005// TI - External validity of randomised controlled trials: “to whom do the results of this trial apply?” JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(04)17670-8 DO - 10.1016/S0140-6736(04)17670-8 ID - Rothwell2005 ER - TY - JOUR AU - Spall, H. G. AU - Wallentin, L. AU - Yusuf, S. AU - Eikelboom, J. W. PY - 2012 DA - 2012// TI - Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial JO - Circulation VL - 126 UR - https://doi.org/10.1161/CIRCULATIONAHA.112.101808 DO - 10.1161/CIRCULATIONAHA.112.101808 ID - Spall2012 ER - TY - JOUR AU - Mega, J. L. AU - Walker, J. R. AU - Ruff, C. T. AU - Vandell, A. G. PY - 2015 DA - 2015// TI - Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61994-2 DO - 10.1016/S0140-6736(14)61994-2 ID - Mega2015 ER - TY - JOUR AU - Vandell, A. G. AU - Walker, J. AU - Brown, K. S. AU - Zhang, G. PY - 2017 DA - 2017// TI - Genetics and clinical response to warfarin and edoxaban in patients with venous thromboembolism JO - Heart VL - 103 UR - https://doi.org/10.1136/heartjnl-2016-310901 DO - 10.1136/heartjnl-2016-310901 ID - Vandell2017 ER - TY - JOUR AU - Johnson, J. A. AU - Caudle, K. E. AU - Gong, L. AU - Whirl-Carrillo, M. PY - 2017 DA - 2017// TI - Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update JO - Clin Pharmacol Ther VL - 102 UR - https://doi.org/10.1002/cpt.668 DO - 10.1002/cpt.668 ID - Johnson2017 ER - TY - JOUR AU - Verhoef, T. I. AU - Redekop, W. K. AU - Langenskiold, S. AU - Kamali, F. PY - 2016 DA - 2016// TI - Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden JO - Pharmacogenomics J VL - 16 UR - https://doi.org/10.1038/tpj.2016.41 DO - 10.1038/tpj.2016.41 ID - Verhoef2016 ER - TY - JOUR AU - Kimmel, S. E. AU - French, B. AU - Kasner, S. E. AU - Johnson, J. A. PY - 2013 DA - 2013// TI - A pharmacogenetic versus a clinical algorithm for warfarin dosing JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1310669 DO - 10.1056/NEJMoa1310669 ID - Kimmel2013 ER - TY - JOUR AU - Pirmohamed, M. AU - Kamali, F. AU - Daly, A. K. AU - Wadelius, M. PY - 2015 DA - 2015// TI - Oral anticoagulation: a critique of recent advances and controversies JO - Trends Pharmacol Sci VL - 36 UR - https://doi.org/10.1016/j.tips.2015.01.003 DO - 10.1016/j.tips.2015.01.003 ID - Pirmohamed2015 ER - TY - JOUR AU - Gage, B. F. B. A. AU - Lin, H. AU - Woller, S. C. AU - Stevens, S. M. AU - Al-Hammadi, N. AU - Li, J. AU - Rodríguez, T. AU - Miller, J. P. AU - McMillin, G. A. AU - Pendleton, R. C. AU - Jaffer, A. K. AU - King, C. R. AU - Whipple, B. D. AU - Porche-Sorbet, R. AU - Napoli, L. AU - Merritt, K. AU - Thompson, A. M. AU - Hyun, G. AU - Anderson, J. L. AU - Hollomon, W. AU - Barrack, R. L. AU - Nunley, R. M. AU - Moskowitz, G. AU - Dávila-Román, V. AU - Eby, C. S. PY - 2017 DA - 2017// TI - Effect of genotype-guided warfarin dosing on clinical events and anticoagulation control among patients undergoing hip or knee arthroplasty: the GIFT randomized clinical trial JO - JAMA VL - 318 UR - https://doi.org/10.1001/jama.2017.11469 DO - 10.1001/jama.2017.11469 ID - Gage2017 ER - TY - JOUR AU - Syn, N. L. AU - Wong, A. L. AU - Lee, S. C. AU - Teoh, H. L. PY - 2018 DA - 2018// TI - Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial JO - BMC Med VL - 16 UR - https://doi.org/10.1186/s12916-018-1093-8 DO - 10.1186/s12916-018-1093-8 ID - Syn2018 ER - TY - JOUR AU - Pirmohamed, M. PY - 2018 DA - 2018// TI - Warfarin: the end or the end of one size fits all JO - J Personalized Med VL - 8 UR - https://doi.org/10.3390/jpm8030022 DO - 10.3390/jpm8030022 ID - Pirmohamed2018 ER - TY - JOUR AU - Gulilat, M. AU - Tang, A. AU - Gryn, S. E. AU - Leong-Sit, P. PY - 2017 DA - 2017// TI - Interpatient variation in rivaroxaban and apixaban plasma concentrations in routine care JO - Can J Cardiol VL - 33 UR - https://doi.org/10.1016/j.cjca.2017.04.008 DO - 10.1016/j.cjca.2017.04.008 ID - Gulilat2017 ER - TY - JOUR AU - Burn, J. AU - Pirmohamed, M. PY - 2018 DA - 2018// TI - Direct oral anticoagulants versus warfarin: is new always better than the old? (vol 5, year 2018) JO - Open Heart VL - 5 UR - https://doi.org/10.1136/openhrt-2017-000712 DO - 10.1136/openhrt-2017-000712 ID - Burn2018 ER -